AFIB - Acutus Medical, Inc.
After hours:
| Previous close | 0.9583 |
| Open | 0.9583 |
| Bid | 0.0000 x 1200 |
| Ask | 0.0000 x 1300 |
| Day's range | 0.8452 - 0.9800 |
| 52-week range | 0.4800 - 2.1500 |
| Volume | |
| Avg. volume | 136,409 |
| Market cap | 24.646M |
| Beta (5Y monthly) | 0.82 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.5900 |
| Earnings date | 09 Aug 2023 - 14 Aug 2023 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 1.75 |
ZacksAcutus Medical, Inc. (AFIB) Q4 Earnings and Revenues Surpass Estimates
Acutus Medical, Inc. (AFIB) delivered earnings and revenue surprises of 158.57% and 3.38%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
ZacksAcutus Medical, Inc. (AFIB) Reports Q3 Loss, Tops Revenue Estimates
Acutus Medical, Inc. (AFIB) delivered earnings and revenue surprises of 13.25% and 3.67%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Motley FoolAcutus Medical, Inc. (AFIB) Q2 2022 Earnings Call Transcript
Joining me on today's call is David Roman, chief executive officer and chief financial officer. This call will include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements made on this call do not relate to matters of historical fact should be considered forward-looking statements.